Literature DB >> 3003200

Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus.

J D Lifson, D T Sasaki, E G Engleman.   

Abstract

To maximize safety in the setting of an increasing number of requests for flow cytometric analysis of specimens potentially contaminated with the AIDS retrovirus, we evaluated some commonly used fixatives for their ability to inactivate the infectious potential of the virus. We found that both formaldehyde (0.37% v/v) and paraformaldehyde (0.5% w/v) completely inactivated the infectious activity of both free and cell-associated lymphadenopathy associated virus (LAV), the etiologic agent for the acquired immunodeficiency syndrome (AIDS). Based on encouraging preliminary results we formally evaluated the effect of formaldehyde fixation on flow cytometric parameters. In addition to inactivating LAV, 0.37% formaldehyde in phosphate buffered saline preserved light scatter and fluorescence properties of cells stained with fluorescein isothiocyanate (FITC) and beta-phycoerythrin (PE) conjugated monoclonal antibodies. These findings suggest that formalin fixation may be useful for laboratories performing flow cytometric analysis of specimens potentially contaminated with the AIDS virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003200     DOI: 10.1016/0022-1759(86)90278-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Evaluation of semiautomated procedure for lymphocyte subset analysis.

Authors:  G J Bryson; R P Keegan; C P Quinn; R J Collins
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

Review 2.  How to develop a standard operating procedure for sorting unfixed cells.

Authors:  Ingrid Schmid
Journal:  Methods       Date:  2012-02-21       Impact factor: 3.608

3.  Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation.

Authors:  M Fauvel; G Ozanne
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

4.  EOS lentiviral vector selection system for human induced pluripotent stem cells.

Authors:  Akitsu Hotta; Aaron Y L Cheung; Natalie Farra; Kamal Garcha; Wing Y Chang; Peter Pasceri; William L Stanford; James Ellis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Fixation of cryo-sections under HIV-1 inactivating conditions: integrity of antigen binding sites and cell surface antigens.

Authors:  J D Laman; N Kors; J L Heeney; W J Boersma; E Claassen
Journal:  Histochemistry       Date:  1991

6.  Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.

Authors:  D Islam; P K Bardhan; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Quantitation of gene expression in formaldehyde-fixed and fluorescence-activated sorted cells.

Authors:  Julia N Russell; Janice E Clements; Lucio Gama
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis.

Authors:  Teridah Ernala Ginting; Salomo Christian; Young Othiwi Larasati; Jeremiah Suryatenggara; Ivet Marita Suriapranata; George Mathew
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

9.  Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.

Authors:  David van Bockel; David A Price; Tedi E Asher; Vanessa Venturi; Kazuo Suzuki; Kristina Warton; Miles P Davenport; David A Cooper; Daniel C Douek; Anthony D Kelleher
Journal:  J Immunol Methods       Date:  2007-08-09       Impact factor: 2.303

10.  Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion.

Authors:  J Lifson; S Coutré; E Huang; E Engleman
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.